JUVE Patent brings you the latest in-house patent market news and developments – from counsel moves, to interviews, to case law developments which impact technical industries.
Dyson adds to patent department with patent attorney from Mathys & Squire
European and UK patent attorney Miranda Kent is moving from European patent attorney firm Mathys & Squire to an in-house role at appliance manufacturer Dyson. During her nine-year stint at Mathys & Squire, Miranda Kent worked her way up from technical assistant through to managing associate. She also spent the past year and a half as expert in residence at Women of Wearables, an organisation by and for women in the femtech, wearable tech and health industries. Kent now moves to the patent department of Dyson as senior patent attorney. She is experienced in prosecution, infringement and oppositions in the fields of engineering, electronics, medical devices, computing and other technologies, such as communications and networking.
Former GSK global head of consumer healthcare patents joins spinoff Haleon
A long-time member of GlaxoSmithKline’s in-house IP team, Michael Lubienski has taken on the role of VP global head of patents with new UK-based healthcare company Haleon, formerly known as GSK Consumer Healthcare. He previously spent 17 years as senior patent counsel at GSK managing bacterial vaccine projects, and represented GSK Biologicals before the EPO. Following a stint as associate general patent counsel at biotech company UCB Celltech, Lubienski returned to GSK where he spent a further five years as VP global head of consumer healthcare patents. The newly-founded Haleon was previously the consumer product division at GSK but demerged from the group in July 2022. The company will focus on consumer health. Lubienski is qualified as a UK and European patent attorney.
Chr. Hansen bolsters life sciences division with new head of IP strategy
Patent attorney Sean Alexander has moved from Elanco to Chr. Hansen, where he joins a 25-strong IP team as head of global IP strategy and portfolio at the company’s health and nutrition department. His decades-long career in life sciences has spanned a number of companies and firms, including Procter & Gamble, Royal DSM and Canadian law firm Gowling WLG. He recently spent six years at Elanco as managing counsel of patent operations in animal health.
ResMed selects former Huawei patent portfolio manager as new director of IP
Pierre-Aimé Despalle, former patent portfolio manager for Chinese telecommunications firm Huawei, has moved on to a new role as director of IP for American health firm ResMed. Pierre-Aimé Despalle has taken on the new role following more than two years with Huawei managing its European wireless technology patent portfolio. Prior to this, he worked on Infineon’s automotive integrated circuit patent portfolio. Staying in Munich, his new role for ResMed, a medical equipment firm, will involve a focus on standard essential patents.
IPCom undergoes major management restructure
Bernhard Frohwitter has left non-practising entity, IPCom. His successor as managing director is Pio Suh. The change in management is being accompanied by a comprehensive reorganisation of the company’s structure.
Thyssenkrupp Elevator to manage IP business independently
In 2020, Thyssenkrupp officially completed the spinoff of its elevator division. Now Thyssenkrupp Elevator AG is managing its own IP business. Nicolas Jacobi is responsible for patents, while Melanie Fischer-Endlich is responsible for soft IP.
Liu Zhen: “We will not bend to intimidation from NPEs”
As Xiaomi expands westwards, protecting its patents in Europe is essential to the company’s developing IP strategy. Liu Zhen, senior legal director and head of global litigation at Xiaomi, speaks to JUVE Patent about Xiaomi’s patent prosecution and litigation strategies, its approach to risk management, and why Xiaomi is still optimistic for a functioning UPC.